| __timestamp | Soleno Therapeutics, Inc. | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 2917513 | 612613000000 |
| Thursday, January 1, 2015 | 7878291 | 650773000000 |
| Friday, January 1, 2016 | 8366794 | 619061000000 |
| Sunday, January 1, 2017 | 6610381 | 628106000000 |
| Monday, January 1, 2018 | 6556000 | 717599000000 |
| Tuesday, January 1, 2019 | 6930000 | 964737000000 |
| Wednesday, January 1, 2020 | 8758000 | 875663000000 |
| Friday, January 1, 2021 | 10806000 | 886361000000 |
| Saturday, January 1, 2022 | 9844000 | 997309000000 |
| Sunday, January 1, 2023 | 13481000 | 1053819000000 |
| Monday, January 1, 2024 | 1053819000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. This chart compares the Selling, General, and Administrative (SG&A) expenses of Takeda Pharmaceutical Company Limited and Soleno Therapeutics, Inc. from 2014 to 2023. Takeda, a global leader, consistently shows SG&A expenses in the hundreds of billions, peaking at approximately $1.05 trillion in 2023. In contrast, Soleno, a smaller player, has expenses in the millions, with a notable increase of 362% from 2014 to 2023. This stark difference highlights the scale and operational scope between a pharmaceutical giant and a niche biotech firm. Interestingly, while Takeda's expenses show a steady upward trend, Soleno's expenses fluctuate, reflecting its dynamic growth phase. Missing data for 2024 suggests ongoing developments. This financial snapshot offers insights into strategic spending and market positioning within the pharmaceutical sector.
SG&A Efficiency Analysis: Comparing AbbVie Inc. and Takeda Pharmaceutical Company Limited
Comparing SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Soleno Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for GSK plc and Soleno Therapeutics, Inc.
Takeda Pharmaceutical Company Limited vs Ascendis Pharma A/S: SG&A Expense Trends
Takeda Pharmaceutical Company Limited vs Opthea Limited: SG&A Expense Trends
Takeda Pharmaceutical Company Limited vs Viridian Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Viatris Inc. vs Soleno Therapeutics, Inc. Trends and Insights
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Breaking Down SG&A Expenses: Halozyme Therapeutics, Inc. vs Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Protagonist Therapeutics, Inc. vs Soleno Therapeutics, Inc. Trends and Insights
SG&A Efficiency Analysis: Comparing Supernus Pharmaceuticals, Inc. and Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc. or Taro Pharmaceutical Industries Ltd.: Who Manages SG&A Costs Better?